Relationship between aberrant methylation of FAS promoter and biological behavior of bladder urothelial carcinoma

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 31, Issue 6, 2011, Pages 794-798

  Li, Wei ^a,b   Xia, Ding ^a   Wang, Yuanbao ^a   Li, Yi ^a   Xue, Yanli ^a   Wu, Xin ^a   Ye, Zhangqun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b People's Hospital of Yunnan Province   (China)

Author keywords

Bladder; Carcinoma; Fas; Methylation

Indexed keywords

DNA; FAS ANTIGEN; FAS PROTEIN, HUMAN;

ARTICLE; BLADDER TUMOR; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; PROMOTER REGION; TUMOR CELL LINE;

ANTIGENS, CD95; CARCINOMA, PAPILLARY; CELL LINE, TUMOR; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROGNOSIS; PROMOTER REGIONS, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 84862929526     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-011-0679-6     Document Type: Article

References (16)

1. Hu ZB. The expression and significance of Fas in human body. Sect Immunol Foreig Med Sci (Chinese), 2000,23(1):8-11
2. Chinnaiyan AM, O'Rourke K, Tewari M, et al. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 1995,81(4):505-512
3. Boldin MP, Mett IL, Varfolomeev EE, et al. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J Biol Chem, 1995,270(1):387-391
4. Luo B. The expression of VEGF and E-cadherin in bladder transitional carcinoma tissue. Acta Academiae Medicinae Qingdao Universitatis (Chinese), 2005,41(4):317-319
5. Chinnaiyan, AM, O'Rourke K, Yu GL, et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science, 1996,274(5289): 990-992 (Pubitemid 26398422)
6. Trauzold A, Schmiedel S, Röder C, et al. Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells. Br J Cancer, 2003,89(9): 1714-1721 (Pubitemid 37464145)
7. Tourneur L, Mistou S, Michiels FM, et al. Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells. Oncogene, 2003,22(18): 2795-2804 (Pubitemid 36609593)
8. Mishima K, Nariai Y, Yoshimura Y. Carboplatin induces Fas (APO-1/CD95)-dependent apoptosis of human tongue carcinoma cells: Sensitization for apoptosis by upregulation of FADD expression. Int J Cancer, 2003, 105(5):593-600 (Pubitemid 36687725)
9. Jeltsch A. Beyond Watson and Crick: DNA methylation and molecular enzymology of DNA methyltransferases. Chembiochem, 2002,3(4):274-293
10. Esteller M. DNA methylation and cancer therapy: New developments and expectations. Curr Opin Oncol, 2005,17(1):55-60 (Pubitemid 40179913)
11. Esteller M, Corn PG, Baylin SB, et al. A gene hypermethylation profile of human cancer. Cancer Res, 2001,61(8):3225-3229 (Pubitemid 32695003)
12. Natarajan AT, Vermeulen S, Darroudi F, et al. Chromosomal localization of human O6-methylguanine-DNA methyltransferase (MGMT) gene by in situ hybridization. Mutagenesis, 1992,7(1):83-85
13. Esteller M, Risques RA, Toyota M, et al. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine- DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res, 2001,61(12):4689-4692 (Pubitemid 32691877)
14. Esteller M, Toyota M, Sanchez-Cespedes M, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res, 2000,60(9):2368-2371 (Pubitemid 30262424)
15. Srivenugopal KS, Ali-Osman F. The DNA repair protein, O(6)-methylguanine-DNA methyltransferase is a prote olytic target for the E6 human papillomavirus oncoprotein. Oncogene, 2002,21(38):5940-5945 (Pubitemid 35007246)
16. Zheng CQ, Ji SP, Gong F, et al. Detection of hypermethylated MGMT, hMLH1 and hMSH2 genes in tumor and serum DNA of gliomas patients. J Med Mol Biol (Chinese), 2009,6(1):1-5